Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Hospital study tests decolonization to stop superbug infections

NCT ID NCT01209234

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a 5-day decolonization routine using nasal ointment, mouth rinse, and body wash could prevent MRSA infections in over 2,000 adults carrying the bacteria after hospital discharge. Participants were randomly assigned to either the decolonization regimen or standard education about MRSA. The goal was to see if the routine reduced infections and re-hospitalizations compared to education alone.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
mupirocin and chlorhexidine
What this could lead to
If successful, this approach could become a standard way to prevent dangerous MRSA infections in people carrying the bacteria, reducing hospital readmissions.
What could go wrong
The trial is completed, but results may show only modest benefit or be limited to certain patient groups. Decolonization may not work for everyone and could cause skin irritation or allergies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

2,140 people

The number who actually took part.

Start date

Jan 2011

Finished

Jan 2019

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 1\) At least 18 years old * 2\) Have had a positive culture (a type of test) for MRSA during recent hospital admission or within the 30 days prior to admission or following discharge * 3\) Able to give consent or have a primary caregiver provide consent * 4\) Able to bathe or shower or have this consistently performed by a willing caregiver Exclusion Criteria: * 1\) Known allergies to chlorhexidine or mupirocin

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Methicillin resistant staphylococcus aureus are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Chapman Care Center

    Garden Grove, California, 92840, United States

  • Country Villa Plaza

    Santa Ana, California, 92707, United States

  • Covington Care Center

    Aliso Viejo, California, 92656, United States

  • Downey Regional Medical Center

    Downey, California, 90241, United States

  • Fountain Valley Regional Hospital & Medical Center

    Fountain Valley, California, 92708, United States

  • Harbor-UCLA Medical Center

    Torrence, California, 90502, United States

  • Hoag Memorial Hospital Presbyterian

    Newport Beach, California, 92658, United States

  • Little Company of Mary - San Pedro

    San Pedro, California, 90732, United States

  • Long Beach Memorial Medical Center

    Long Beach, California, 90806, United States

  • Mission Hospital

    Mission Viejo, California, 92691, United States

  • Orange Coast Memorial Medical Center

    Fountain Valley, California, 92708, United States

  • Pacific Haven HealthCare Center

    Garden Grove, California, 92843, United States

  • Providence Little Company of Mary Medical Center

    Torrance, California, 90732, United States

  • Regents Point at Windcrest

    Irvine, California, 92612, United States

  • Royale Healthcare

    Santa Ana, California, 92707, United States

  • Saddleback Memorial Medical Center - Laguna Hills

    Laguna Hills, California, 92653, United States

  • Saddleback Memorial Medical Center - San Clemente

    San Clemente, California, 92673, United States

  • St. Jude Medical Center

    Fullerton, California, 92835, United States

  • St. Mary Medical Center

    Long Beach, California, 90813, United States

  • Torrance Memorial Medical Center

    Torrance, California, 90505, United States

  • UC Irvine Medical Center

    Orange, California, 92868, United States

  • Ventura County Medical Center

    Ventura, California, 93003, United States

  • Villa Elena Health Care Center

    Norwalk, California, 90650, United States

  • West Anaheim Extended Care

    Anaheim, California, 92804, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.